Ganesh Mohan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ganesh Mohan has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Shamee Shastry
Department of Immunohematology and Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India
20 shared publications - Deepika Chenna
Department of Immunohematology and Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India
8 shared publications - Dhivya Kandasamy
Department of Immunohematology and Blood Transfusion Manipal Karnataka 576104 Kasturba Medical College, Manipal, Manipal Academy of Higher Education
6 shared publications - Santhosh Chidangil
Centre of Excellence for Biophotonics, Department of Atomic and Molecular Physics, Manipal Academy of Higher Education, Manipal, India
5 shared publications - Jijo Lukose
Centre of Excellence for Biophotonics, Department of Atomic and Molecular Physics, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India
4 shared publications - Jayaraj Mymbilly Balakrishnan
Department of Emergency Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
3 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (22)
Standardization of the Monocyte Monolayer Assay: Lessons Learned From Laboratory Optimization and Literature Review
Objectives: Several variables influence the outcome of cellular assays. We conducted a comprehensive literature review to identify the factors affecting the Monocyte Monolayer Assay (MMA) and subsequently standardized the assay through systematic in‐house laboratory trials. Methods: The study was conducted in two phases. Phase 1 involved a literature review using PubMed and Scopus databases to identify factors influencing the assay. Phase 2 included experimental trials to evaluate the effects of these factors. Monocytes were isolated from buffy coat bags, and assay parameters, such as centrifugation speed, monocyte adherence conditions, RBC sensitization, incubation time, and staining, were systematically standardized. A blinded evaluation was employed for slide reading to assess the influence of procedural factors on assay reliability. Results: A literature review using the PubMed and Scopus databases identified key variables influencing MMA performance. Twelve sequential trials were conducted to identify the effects of these variables on assay outcome. Optimal centrifugation speed and time was 600 × g for 15 min, and the use of four buffy coat bags improved monocyte yield to 8.3 × 10 6 /mL. Dilution with Phosphate buffer saline (PBS, pH 7.2) and use of Histopaque provided consistent cell recovery. A 1‐h incubation yielded optimal monocyte adherence with minimal lysis. The final protocol demonstrated high reproducibility and improved visualization of phagocytosis. Conclusion: This study emphasizes the importance of standardizing the MMA procedure before implementation. Optimizing the parameters to ensure enhanced monocyte yield, reduced cell lysis, and reliable interpretation for assessing the clinical significance of red cell alloantibodies is essential.
- 20 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (22)
Open AccessStandardization of the Monocyte Monolayer Assay: Lessons Learned From Laboratory Optimization and Literature Review
Objectives: Several variables influence the outcome of cellular assays. We conducted a comprehensive literature review to identify the factors affecting the Monocyte Monolayer Assay (MMA) and subsequently standardized the assay through systematic in‐house laboratory trials. Methods: The study was conducted in two phases. Phase 1 involved a literature review using PubMed and Scopus databases to identify factors influencing the assay. Phase 2 included experimental trials to evaluate the effects of these factors. Monocytes were isolated from buffy coat bags, and assay parameters, such as centrifugation speed, monocyte adherence conditions, RBC sensitization, incubation time, and staining, were systematically standardized. A blinded evaluation was employed for slide reading to assess the influence of procedural factors on assay reliability. Results: A literature review using the PubMed and Scopus databases identified key variables influencing MMA performance. Twelve sequential trials were conducted to identify the effects of these variables on assay outcome. Optimal centrifugation speed and time was 600 × g for 15 min, and the use of four buffy coat bags improved monocyte yield to 8.3 × 10 6 /mL. Dilution with Phosphate buffer saline (PBS, pH 7.2) and use of Histopaque provided consistent cell recovery. A 1‐h incubation yielded optimal monocyte adherence with minimal lysis. The final protocol demonstrated high reproducibility and improved visualization of phagocytosis. Conclusion: This study emphasizes the importance of standardizing the MMA procedure before implementation. Optimizing the parameters to ensure enhanced monocyte yield, reduced cell lysis, and reliable interpretation for assessing the clinical significance of red cell alloantibodies is essential.
- Open Access
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 122-127
Categorizing Sepsis-induced Coagulopathy Using Thromboelastography: An Approach to Address the Second Pillar of Patient Blood Management
A severity-matched case-control study was done to analyze the efficacy of thromboelastography (TEG) in diagnosing and categorizing sepsis-induced coagulopathy (SIC) by addressing the second pillar of patient blood management, i.e., minimizing bleeding and blood loss. Sepsis-induced coagulopathy managed with TEG data was collected from 2020 to 2021, and severity-matched retrospective data where SIC managed with conventional tests was collected from 2018 to 2019, which comprised the control group. Age > 18 years, SIC requiring critical care admission were the inclusion criteria. The Sequential Organ Failure Assessment (SOFA) scoring system was used for severity matching. Coagulopathy was defined as an abnormal coagulation screen or TEG parameters. A total of 125 patients were included in the TEG-based management, and 118 in the control group. Out of 125, TEG-based diagnosis showed normal, hypo, and hypercoagulable status in 26, 66, and 33 patients, respectively. Hypocoagulable picture was more predominant with an increase in the SOFA score. Severity-matched control group analysis showed that individualized hemostasis management with TEG resulted in a 58% reduction in mortality rate (from 91.67% to 38.4%, p ≤ 0.0001). A hypocoagulable TEG had a higher risk of mortality (OR = 1.89, CI = 0.909–3.963). Kaplan–Meier survival analysis showed that individualized management of SIC had a favorable outcome using TEG-based data (Log rank 12.4, p < 0.001). Patient blood management in SIC with TEG differentiates hypercoagulable from hypocoagulable patients, thus providing clarity in clinical decision-making to improve patient survival. Vaidya A, Mohan G, Rao S, Shastry S. Categorizing Sepsis-induced Coagulopathy Using Thromboelastography: An Approach to Address the Second Pillar of Patient Blood Management. Indian J Crit Care Med 2026;30(2):122–127.
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 122-127
Open AccessCategorizing Sepsis-induced Coagulopathy Using Thromboelastography: An Approach to Address the Second Pillar of Patient Blood Management
A severity-matched case-control study was done to analyze the efficacy of thromboelastography (TEG) in diagnosing and categorizing sepsis-induced coagulopathy (SIC) by addressing the second pillar of patient blood management, i.e., minimizing bleeding and blood loss. Sepsis-induced coagulopathy managed with TEG data was collected from 2020 to 2021, and severity-matched retrospective data where SIC managed with conventional tests was collected from 2018 to 2019, which comprised the control group. Age > 18 years, SIC requiring critical care admission were the inclusion criteria. The Sequential Organ Failure Assessment (SOFA) scoring system was used for severity matching. Coagulopathy was defined as an abnormal coagulation screen or TEG parameters. A total of 125 patients were included in the TEG-based management, and 118 in the control group. Out of 125, TEG-based diagnosis showed normal, hypo, and hypercoagulable status in 26, 66, and 33 patients, respectively. Hypocoagulable picture was more predominant with an increase in the SOFA score. Severity-matched control group analysis showed that individualized hemostasis management with TEG resulted in a 58% reduction in mortality rate (from 91.67% to 38.4%, p ≤ 0.0001). A hypocoagulable TEG had a higher risk of mortality (OR = 1.89, CI = 0.909–3.963). Kaplan–Meier survival analysis showed that individualized management of SIC had a favorable outcome using TEG-based data (Log rank 12.4, p < 0.001). Patient blood management in SIC with TEG differentiates hypercoagulable from hypocoagulable patients, thus providing clarity in clinical decision-making to improve patient survival. Vaidya A, Mohan G, Rao S, Shastry S. Categorizing Sepsis-induced Coagulopathy Using Thromboelastography: An Approach to Address the Second Pillar of Patient Blood Management. Indian J Crit Care Med 2026;30(2):122–127.
- Open Access
- 10 November 2025
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 25 (1) , 227
Clinical utility of Thromboelastography in patients with COVID-19: a prospective observational study
Introduction: Coronavirus disease (COVID-19) has been associated with thromboembolic and bleeding complications. Our study aims to understand the utility of early Thromboelastography (TEG) in the emergency department as a point-of-care test in predicting clinical outcomes. Materials and methodology: A prospective observational study was conducted in the emergency medicine department (ED) during June 2021- May 2022 with inclusion criteria of all patients above 18 years who arrived at the ED and had a positive COVID-19 RT PCR test. Hematological investigation, including TEG, was sent. Patients were followed up for 28-day mortality, thrombotic and bleeding complications. Results: A total of 166 patients were enrolled in the study. 46% of patients had critical COVID-19. TEG was abnormal in 45% of patients. Hypercoagulability was seen in 32% of patients. 28-day mortality in our study population was 32.3%. The most common thrombotic complications were stroke (4.2%), myocardial infarction (3.6%), pulmonary embolism (1.2%), and DVT (0.6%). Logistic regression analysis showed that patients who had hypocoagulable TEG had a higher 28-day mortality. Conclusion: COVID-associated coagulopathy can be associated with both thrombotic (venous and arterial) and bleeding complications. Hypocoagulability on initial TEG has a 7.49 times increased risk of mortality. Hypocoagulable TEG indicates an early predictor for mortality. Early TEG can be an essential tool in managing COVID-associated coagulopathy.
- 10 November 2025
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 25 (1) , 227
Open AccessClinical utility of Thromboelastography in patients with COVID-19: a prospective observational study
Introduction: Coronavirus disease (COVID-19) has been associated with thromboembolic and bleeding complications. Our study aims to understand the utility of early Thromboelastography (TEG) in the emergency department as a point-of-care test in predicting clinical outcomes. Materials and methodology: A prospective observational study was conducted in the emergency medicine department (ED) during June 2021- May 2022 with inclusion criteria of all patients above 18 years who arrived at the ED and had a positive COVID-19 RT PCR test. Hematological investigation, including TEG, was sent. Patients were followed up for 28-day mortality, thrombotic and bleeding complications. Results: A total of 166 patients were enrolled in the study. 46% of patients had critical COVID-19. TEG was abnormal in 45% of patients. Hypercoagulability was seen in 32% of patients. 28-day mortality in our study population was 32.3%. The most common thrombotic complications were stroke (4.2%), myocardial infarction (3.6%), pulmonary embolism (1.2%), and DVT (0.6%). Logistic regression analysis showed that patients who had hypocoagulable TEG had a higher 28-day mortality. Conclusion: COVID-associated coagulopathy can be associated with both thrombotic (venous and arterial) and bleeding complications. Hypocoagulability on initial TEG has a 7.49 times increased risk of mortality. Hypocoagulable TEG indicates an early predictor for mortality. Early TEG can be an essential tool in managing COVID-associated coagulopathy.
- 8 August 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (4) , 357-363
Stratification of blood donors and understanding motivational and deterrent factors to develop effective recruitment strategies
- 8 August 2025
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (4) , 357-363
Stratification of blood donors and understanding motivational and deterrent factors to develop effective recruitment strategies
- 7 May 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (5) , 1140-1145
Assessment of Bleeding in Acute Febrile Illness with Thrombocytopenia Using Thromboelastography and Conventional Coagulation Parameters in the Emergency Department (ABATE): A Prospective Cohort Study
: Acute febrile illnesses (AFIs) with thrombocytopenia, such as dengue, leptospirosis, and scrub typhus, are often associated with bleeding and present challenges in transfusion therapy during outbreaks. Conventional bleeding predictors, which involve platelet counts, do not assess clot strength or fibrinolysis defects and may lead to inappropriate or delayed transfusions. To predict bleeding, we aimed to create a scoring system using point-of-care thromboelastography (TEG) and other conventional coagulation parameters. In this prospective cohort study, patients with AFI and platelet counts <100,000/cu mm who presented to the emergency department were recruited, and samples were collected for conventional coagulation tests and TEG analysis at admission. Patients were monitored for 48 hours for bleeding events, blood product transfusions, and mortality within 7 days. Receiver operating characteristic curves were plotted for significant predictors identified in univariate analysis, and a scoring system was generated using stepwise logistic regression. Sixty-six patients were recruited, including 38 with dengue and 11 with leptospirosis. Nineteen patients experienced a bleeding event within 48 hours. Dyspnea and elevated aspartate transaminase levels were more prevalent among those who bled. Thromboelastography parameters (reaction time/maximum amplitude [R/MA]), prothrombin time, international normalized ratio (INR), and baseline platelet count were significant predictors of bleeding. A scoring system using R/MA, INR, and platelet count achieved an overall predictive accuracy of 83.3% for 48-hour bleeding, with a score ≥3 demonstrating a sensitivity of 68% and specificity of 77%. Thromboelastography in patients with dengue showed more significant coagulation abnormalities than in those with leptospirosis. Validation in larger, more homogeneous populations is necessary.
- 7 May 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112 (5) , 1140-1145
Assessment of Bleeding in Acute Febrile Illness with Thrombocytopenia Using Thromboelastography and Conventional Coagulation Parameters in the Emergency Department (ABATE): A Prospective Cohort Study
: Acute febrile illnesses (AFIs) with thrombocytopenia, such as dengue, leptospirosis, and scrub typhus, are often associated with bleeding and present challenges in transfusion therapy during outbreaks. Conventional bleeding predictors, which involve platelet counts, do not assess clot strength or fibrinolysis defects and may lead to inappropriate or delayed transfusions. To predict bleeding, we aimed to create a scoring system using point-of-care thromboelastography (TEG) and other conventional coagulation parameters. In this prospective cohort study, patients with AFI and platelet counts <100,000/cu mm who presented to the emergency department were recruited, and samples were collected for conventional coagulation tests and TEG analysis at admission. Patients were monitored for 48 hours for bleeding events, blood product transfusions, and mortality within 7 days. Receiver operating characteristic curves were plotted for significant predictors identified in univariate analysis, and a scoring system was generated using stepwise logistic regression. Sixty-six patients were recruited, including 38 with dengue and 11 with leptospirosis. Nineteen patients experienced a bleeding event within 48 hours. Dyspnea and elevated aspartate transaminase levels were more prevalent among those who bled. Thromboelastography parameters (reaction time/maximum amplitude [R/MA]), prothrombin time, international normalized ratio (INR), and baseline platelet count were significant predictors of bleeding. A scoring system using R/MA, INR, and platelet count achieved an overall predictive accuracy of 83.3% for 48-hour bleeding, with a score ≥3 demonstrating a sensitivity of 68% and specificity of 77%. Thromboelastography in patients with dengue showed more significant coagulation abnormalities than in those with leptospirosis. Validation in larger, more homogeneous populations is necessary.
- Open Access
- 9 September 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (11) , 1183-1190
A comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators
Background and Objectives: To develop key performance indicators (KPI) for use in quality assessment of our institutional goal‐directed massive transfusion (GDMT).Materials and Methods: A team comprising our transfusion and emergency medicine departments carried out a cross‐sectional data analysis of GDMT in adult patients from January 2021 to December 2022. The study was rooted in the Define, Measure, Analyse, Improve, Control (DMAIC) approach. Features of KPIs were (a) importance, (b) scientific soundness and (c) feasibility. Study parameters were defined and analysed using measures of central tendencies and benchmark comparison.Results: Ninety‐two massive transfusion events occurred and 1405 blood components were used. Trauma was the leading cause, followed by postpartum haemorrhage and upper gastrointestinal bleeding. Appropriate GDMT activation was observed only in 43.47% of events. The turnaround time (TAT) was within the benchmark in 85.8% of events with an average of 16 ± 10 min. The average utilization of blood components was 20.5 (interquartile range [IQR] = 11.3) in the appropriate group and 5.5 (IQR = 4.25) in the inappropriate group with a wastage rate of 3.5%. Duration of activation was 6.19 ± 4.59 h, and the adherence to thromboelastography was 66.3%. Overall mortality was 45.65%, and the average duration of hospital stay was 6.1 ± 5.9 days.Conclusion: The KPIs developed were easy to capture, and the analysis provided a comprehensive approach to the quality improvement of the GDMT protocol.
- 9 September 2024
- Published by Wiley in Vox Sanguinis
- Vol. 119 (11) , 1183-1190
Open AccessA comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators
Background and Objectives: To develop key performance indicators (KPI) for use in quality assessment of our institutional goal‐directed massive transfusion (GDMT).Materials and Methods: A team comprising our transfusion and emergency medicine departments carried out a cross‐sectional data analysis of GDMT in adult patients from January 2021 to December 2022. The study was rooted in the Define, Measure, Analyse, Improve, Control (DMAIC) approach. Features of KPIs were (a) importance, (b) scientific soundness and (c) feasibility. Study parameters were defined and analysed using measures of central tendencies and benchmark comparison.Results: Ninety‐two massive transfusion events occurred and 1405 blood components were used. Trauma was the leading cause, followed by postpartum haemorrhage and upper gastrointestinal bleeding. Appropriate GDMT activation was observed only in 43.47% of events. The turnaround time (TAT) was within the benchmark in 85.8% of events with an average of 16 ± 10 min. The average utilization of blood components was 20.5 (interquartile range [IQR] = 11.3) in the appropriate group and 5.5 (IQR = 4.25) in the inappropriate group with a wastage rate of 3.5%. Duration of activation was 6.19 ± 4.59 h, and the adherence to thromboelastography was 66.3%. Overall mortality was 45.65%, and the average duration of hospital stay was 6.1 ± 5.9 days.Conclusion: The KPIs developed were easy to capture, and the analysis provided a comprehensive approach to the quality improvement of the GDMT protocol.
- Open Access
- 5 June 2024
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 51 (6) , 1-9
Advancing Transfusion Medicine through Raman Tweezers Spectroscopy: A Review of Recent Progress and Future Perspectives
Background: Raman tweezers spectroscopy (RTS) is a powerful tool that combines optical tweezers and Raman spectroscopy to study single living cells. RTS has become increasingly popular in biomedical and clinical research due to its high molecular specificity and sensitivity, which enable the study of cell viability, cell deformation, cell-protein, cell-nanoparticle, cell-cell interaction, etc. In transfusion medicine, RTS can give valuable insights into the storage lesions and effects of various preservatives and intravenous fluids on blood cells. Summary: By analyzing the Raman spectra of individual blood cells, RTS can detect changes in the cellular blood components which can be used to monitor the quality of blood products during storage and transfusion. The present review article highlights the principle and clinical applications of RTS in transfusion medicine. Key Messages: Raman spectroscopy is a versatile analytical method for biomedical research. Combining the Raman spectroscopy method with the optical tweezers technique will allow us to explore the dynamics of live single cells in their physiological medium.
- 5 June 2024
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 51 (6) , 1-9
Open AccessAdvancing Transfusion Medicine through Raman Tweezers Spectroscopy: A Review of Recent Progress and Future Perspectives
Background: Raman tweezers spectroscopy (RTS) is a powerful tool that combines optical tweezers and Raman spectroscopy to study single living cells. RTS has become increasingly popular in biomedical and clinical research due to its high molecular specificity and sensitivity, which enable the study of cell viability, cell deformation, cell-protein, cell-nanoparticle, cell-cell interaction, etc. In transfusion medicine, RTS can give valuable insights into the storage lesions and effects of various preservatives and intravenous fluids on blood cells. Summary: By analyzing the Raman spectra of individual blood cells, RTS can detect changes in the cellular blood components which can be used to monitor the quality of blood products during storage and transfusion. The present review article highlights the principle and clinical applications of RTS in transfusion medicine. Key Messages: Raman spectroscopy is a versatile analytical method for biomedical research. Combining the Raman spectroscopy method with the optical tweezers technique will allow us to explore the dynamics of live single cells in their physiological medium.
- Open Access
- 18 April 2024
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 39 (3) , e22110
Assessing the clinical efficacy of low‐volume therapeutic plasma exchange in achieving recovery from acute liver failure induced by yellow phosphorous poisoning
Background: Acute liver failure (ALF) following yellow phosphorous (YP) ingestion is similar to acetaminophen‐induced ALF and it has become a public concern in our region. This study assessed low volume therapeutic plasma exchange (LV‐TPE) efficacy in improving the transplant free survival in YP poisoning.Methods: Adult patients with toxicology reports of YP and ALF requiring critical care were included in the study. LV‐TPE was planned for three consecutive days and three more if required. Performed 1.3 to 1.5 plasma volume replacing with 0.9% normal saline, 5% human albumin solution, and fresh frozen plasma based on ASFA 2019 criteria. MELD score, laboratory parameters, LV‐TPE details were captured. The study end point was clinical outcome of the patients.Results: Among 36 patients, 19 underwent LV‐TPE and 17 opted out of LV‐TPE and they were included as a control arm. The MELD score was 32.64 ± 8.05 and 37.83 ± 9.37 in both groups. There were 13 survivors in LV‐TPE group leading to a 68.42% reduction in mortality. The coagulation and biochemical parameters showed a significant percentage change after LV‐TPE. Refractory shock, delay in initiating procedure and acidosis were independent predictors of mortality.Conclusion: A well‐timed LV‐TPE improves the survival of patients with ALF due to YP poisoning.
- 18 April 2024
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 39 (3) , e22110
Open AccessAssessing the clinical efficacy of low‐volume therapeutic plasma exchange in achieving recovery from acute liver failure induced by yellow phosphorous poisoning
Background: Acute liver failure (ALF) following yellow phosphorous (YP) ingestion is similar to acetaminophen‐induced ALF and it has become a public concern in our region. This study assessed low volume therapeutic plasma exchange (LV‐TPE) efficacy in improving the transplant free survival in YP poisoning.Methods: Adult patients with toxicology reports of YP and ALF requiring critical care were included in the study. LV‐TPE was planned for three consecutive days and three more if required. Performed 1.3 to 1.5 plasma volume replacing with 0.9% normal saline, 5% human albumin solution, and fresh frozen plasma based on ASFA 2019 criteria. MELD score, laboratory parameters, LV‐TPE details were captured. The study end point was clinical outcome of the patients.Results: Among 36 patients, 19 underwent LV‐TPE and 17 opted out of LV‐TPE and they were included as a control arm. The MELD score was 32.64 ± 8.05 and 37.83 ± 9.37 in both groups. There were 13 survivors in LV‐TPE group leading to a 68.42% reduction in mortality. The coagulation and biochemical parameters showed a significant percentage change after LV‐TPE. Refractory shock, delay in initiating procedure and acidosis were independent predictors of mortality.Conclusion: A well‐timed LV‐TPE improves the survival of patients with ALF due to YP poisoning.
- Open Access
- 1 January 2024
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 18 (1) , 7-15
Tailoring transfusion strategy using thromboelastogram in goal-directed massive transfusion: Impact on transfusion requirements and clinical outcomes
BACKGROUND AND OBJECTIVE: We compared the overall clinical outcome in formula-based protocol (1:1:1) and thromboelastogram (TEG)-guided goal-based massive transfusion (MT) in the resuscitation of patients with hemorrhagic shock. MATERIALS AND METHODS: This was a retro-prospective case–control study conducted over a period of 2 years among the patients who received MT using a 1:1:1 fixed ratio protocol (controls, Group A) and goal-based protocol (cases, Group B) guided through TEG. Patients were matched for the type and severity of the clinical conditions. Utilization of blood components, clinical outcomes, transfusion-related complications, and total mortality rates were compared between the groups. RESULTS: There were 113 patients in the formula-based group and 109 patients in the goal-based transfusion group who were matched for injury severity scores. The total blood components utilized were 1867 and 1560, respectively, with a 17.7% reduction associated with the use of TEG. Patients were divided into normal, hypo, and hypercoagulable based on TEG, and a higher transfusion rate was associated with hypocoagulable TEG (942 vs. 610). The prothrombin time, activated partial thromboplastin time, R time, and K time had a significant positive correlation with the need to transfuse more than 20 blood components, whereas platelet count, base excess, alpha angle, MA, and CI had a negative correlation (r = 0.268, P < 0.001). At the end of goal-directed transfusion, 75% of the patients were free of transfusion support (vs. 65.4%) and only 6.9% of the patients had coagulopathy (vs. 31.8%) compared to formula-based resuscitation with a 10% reduction in mortality. CONCLUSION: TEG-guided goal-based approach helped to reduce blood component utilization with a reduced incidence of coagulopathy at the end of the MT while improving patient survival.
- 1 January 2024
- Published by Medknow in Asian Journal of Transfusion Science
- Vol. 18 (1) , 7-15
Open AccessTailoring transfusion strategy using thromboelastogram in goal-directed massive transfusion: Impact on transfusion requirements and clinical outcomes
BACKGROUND AND OBJECTIVE: We compared the overall clinical outcome in formula-based protocol (1:1:1) and thromboelastogram (TEG)-guided goal-based massive transfusion (MT) in the resuscitation of patients with hemorrhagic shock. MATERIALS AND METHODS: This was a retro-prospective case–control study conducted over a period of 2 years among the patients who received MT using a 1:1:1 fixed ratio protocol (controls, Group A) and goal-based protocol (cases, Group B) guided through TEG. Patients were matched for the type and severity of the clinical conditions. Utilization of blood components, clinical outcomes, transfusion-related complications, and total mortality rates were compared between the groups. RESULTS: There were 113 patients in the formula-based group and 109 patients in the goal-based transfusion group who were matched for injury severity scores. The total blood components utilized were 1867 and 1560, respectively, with a 17.7% reduction associated with the use of TEG. Patients were divided into normal, hypo, and hypercoagulable based on TEG, and a higher transfusion rate was associated with hypocoagulable TEG (942 vs. 610). The prothrombin time, activated partial thromboplastin time, R time, and K time had a significant positive correlation with the need to transfuse more than 20 blood components, whereas platelet count, base excess, alpha angle, MA, and CI had a negative correlation (r = 0.268, P < 0.001). At the end of goal-directed transfusion, 75% of the patients were free of transfusion support (vs. 65.4%) and only 6.9% of the patients had coagulopathy (vs. 31.8%) compared to formula-based resuscitation with a 10% reduction in mortality. CONCLUSION: TEG-guided goal-based approach helped to reduce blood component utilization with a reduced incidence of coagulopathy at the end of the MT while improving patient survival.
- 16 November 2022
- Published by SAGE Publications in Clinical Hemorheology and Microcirculation
- Vol. 82 (2) , 193-198
ADAMTS13 factor deficiency in severe COVID-19 may not be immune mediated – report from a pilot study
BACKGROUND: The assessment of ADAMTS13 factor activity and inhibitor levels was conducted in severe COVID-19 patients as an observational study. RESULTS: A total of 14 patients were included and the average ADAMTS13 activity level at the time of admission was 28.54±30.74% (range 1.83–86.67%) which was reduced compared to controls (88.09±14.77). Nine patients had reduced ADAMTS13 factor activity (<40%) and 77.7% among them had severe deficiency (15 IU/mL) only in two patients and an overall mean value was 8.15±5.8. Elevated D-Dimer and length of hospital stay had significant correlation with ADAMTS13 activity (–0.247 and 0.306 respectively). No features of thrombotic microangiopathy were observed and hence no plasma exchange was performed. CONCLUSION: Reduced ADAMTS13 factor activity without inhibitor development may give a clue to the disease progress in COVID-19.
- 16 November 2022
- Published by SAGE Publications in Clinical Hemorheology and Microcirculation
- Vol. 82 (2) , 193-198
ADAMTS13 factor deficiency in severe COVID-19 may not be immune mediated – report from a pilot study
BACKGROUND: The assessment of ADAMTS13 factor activity and inhibitor levels was conducted in severe COVID-19 patients as an observational study. RESULTS: A total of 14 patients were included and the average ADAMTS13 activity level at the time of admission was 28.54±30.74% (range 1.83–86.67%) which was reduced compared to controls (88.09±14.77). Nine patients had reduced ADAMTS13 factor activity (<40%) and 77.7% among them had severe deficiency (15 IU/mL) only in two patients and an overall mean value was 8.15±5.8. Elevated D-Dimer and length of hospital stay had significant correlation with ADAMTS13 activity (–0.247 and 0.306 respectively). No features of thrombotic microangiopathy were observed and hence no plasma exchange was performed. CONCLUSION: Reduced ADAMTS13 factor activity without inhibitor development may give a clue to the disease progress in COVID-19.